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Cutaneous
Anthrax, Belgian
Traveler 
To the Editor: Anthrax is a rare
zoonotic disease among travelers. The
clinical spectrum includes cutaneous
lesions, respiratory anthrax, pharyn-
geal inflammation, gastrointestinal
infection, septicemia, and meningitis.
Interest in anthrax increased after the
bioterrorist attacks in the United
States in 2001. The following case
history describes a cutaneous infec-
tion suspected to be anthrax in a
tourist who had indirect contact with
dead mammals in a disease-endemic
area. 
After indirect contact with dead
antelopes and a hippopotamus in
Botswana, an acute necrotic lesion
developed on a finger of a 31-year-
old, healthy, female Belgian woman.
The lesion became covered with a
black crust, followed by massive
swelling of the hand and arm. The
clinical aspect and history strongly
suggested cutaneous anthrax. This
diagnosis was supported by serocon-
version to protective antigen of
Bacillus anthracis and the presence of
antibodies against lethal factor. The
bacterium itself could not be cultured
or identified by polymerase chain
reaction (PCR). Other members of the
group with which she traveled were
contacted, but no other cases were
reported. 
The Belgian woman traveled with
friends to Namibia, Botswana, and
South Africa from December 12,
2004, until January 22, 2005. She vis-
ited Chobe National Park in Botswana
early January 2005. On January 8, a
small, painless, vesicular lesion
developed on the dorsal side of her
fourth left finger. This lesion
increased in size quickly and devel-
oped a black aspect with a red elevat-
ed border. Small vesicles appeared in
the immediate vicinity of the primary
lesion. No pus was noted. Her general
condition was good. She treated her-
self with amoxicillin-clavulanic acid
2 gm/day for 3 days. The next day,
massive edema of the finger, hand,
and left arm developed. When admit-
ted to a hospital in Johannesburg, her
left arm and hand were massively
swollen with painful left axillary lym-
phadenopathy. Her temperature never
exceeded 37.8°C. Wound cultures
showed only the presence of viridans
streptococci, bacteria that are not
implicated in wound infections. The
patient was treated with intravenous
ciprofloxacin, gentamicin, tetracy-
cline, flucloxacillin, and topical
mupirocin. She was discharged after 6
days with oral flucloxacillin and
returned to Belgium on January 22.
On February 4, her general condition
was excellent; the edema had dimin-
ished. A painless necrotic lesion on
the left fourth finger measured 3 cm2
(Figure). She mentioned minor dis-
comfort of her left underarm and loss
of sensation at the distal radial side of
the left underarm. She could not
extend the terminal phalanx of the
fourth left finger because the underly-
ing tendon had been destroyed. The
left axillary lymph nodes were still
slightly swollen. No evidence indicat-
ed parapox viral infection or necrotic
arachnidism. Upon questioning, she
mentioned that in Chobe National
Park, some fellow travelers had
manipulated the legs of dead
antelopes. One person had climbed on
a dead hippo for a picture and sank
into the putrefying carcass. He soon
afterwards cleaned a small abrasion
on the patient’s finger. Some hours
later, all group members washed their
hands in a common small plastic
basin containing water and chlorox-
ylenol. 
Full blood count, erythrocyte sedi-
mentation rate, and biochemistry were
normal. Antistreptolysin O levels
were within normal limits. Serologic
test results for rickettsiae, orthopox-
viruses, and Bartonella henselae were
negative. The patient was not
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immunocompromised. Because cuta-
neous anthrax was suspected, wound
crusts, swabs for bacterial cultures,
and Dacron swabs used for PCR were
mailed as quickly as possible to the
Belgian national reference laboratory.
All cultures remained sterile. PCR
was negative for B. anthracis. Because
of the positive clinical outcome with
antimicrobial drugs for 16 days, no
additional antimicrobial drugs or
steroids were prescribed. Further
recovery was uneventful and only a
small scar remains. While waiting for
serologic test results, a ProMed alert
was issued (1). Members of the travel
group were contacted and warned but
no other cases were identified.
Consecutive serum samples were ana-
lyzed for B. anthracis protective anti-
gen antibodies (anti-PA) (Centers for
Disease Control and Prevention,
Atlanta, GA, USA). The serum col-
lected on February 4 was negative. On
February 16, anti-PA immunoglobulin
G (IgG) was detected with a titer of
9.5 (weakly positive). On April 18, no
anti-PA IgG could be detected. Paired
serum samples (February 4 and 16)
were also mailed to the Institut für
Microbiologie der Bundeswehr in
Munich, Germany. In the German lab-
oratory, the anti-PA enzyme-linked
immunosorbent assay result was nega-
tive, but specific antibodies against
lethal factor of B. anthracis were
detected. 
Anthrax is essentially a disease of
grazing animals and is relatively com-
mon in persons who have contact with
these animals (2–4). It is occasionally
reported in travelers (5). In this case,
many arguments existed for cutaneous
anthrax, but the diagnosis could not
be proven. Clinical symptoms (malig-
nant edema) and history of indirect
contact with carcasses of wildlife in a
disease-endemic area suggested
anthrax. Bacterial cultures remained
negative, presumably because of pre-
vious administration of antimicrobial
drugs. The clinical diagnosis was sup-
ported by seroconversion to protec-
tive antigen and the presence of anti-
bodies against lethal factor. In cuta-
neous anthrax, antibodies to protec-
tive antigen develop in 68%–92% of
cases (6,7). Previous cases of cuta-
neous anthrax in Belgium date from
the 1980s, when a man became infect-
ed while unloading Indian bone meal
in Antwerp Harbor. In 1986, cuta-
neous anthrax developed in a Turkish
woman after being injured while
cooking a sheep (8). In 2002, a sus-
pected case in a Belgian farmer was
reported (9). Many cases of cutaneous
anthrax heal spontaneously, but a
5%–10% chance of systemic compli-
cations exists. This case illustrates 1
of the dangers of touching dead ani-
mals in nature. Travelers should be
warned that even indirect contact can
lead to problems.
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Figure. Initial skin lesion, suggestive of cutaneous anthrax. By the time the picture was
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Japanese
Encephalitis,
Singapore
To the Editor: Japanese encephal-
itis (JE) is an endemic flavivirus dis-
ease in Asia. The JE virus (JEV) is
one of the leading causes of viral
encephalitis: 35,000–50,000 cases
occur every year (1). While most
infections are subclinical, the disease
has a high case-fatality rate (≈25%)
and considerable incidence of serious
neurologic sequelae with the develop-
ment of overt meningoencephalitis
(1).
JEV is transmitted principally by
Culex tritaeniorhynchus and less fre-
quently by Cx. vishnui and  Cx.
gelidus, which breed in flooded rice
fields. The virus circulates in water-
fowl such as herons and egrets, and
pigs serve as amplifying hosts. Hence,
the distribution of JEV is significantly
linked to irrigated rice production and
pig rearing (2). 
JEV was previously endemic in
Singapore, but since the phasing out
of pig farming (completed in 1992),
the incidence of reported disease has
become very low. Routine serologic
testing for JEV has correspondingly
been dropped from local hospital
microbiology laboratories. We
describe an indigenous case of JEV
meningoencephalitis in Singapore.
In May 2005, a 53-year-old previ-
ously healthy man of Chinese ethnici-
ty was seen at Singapore General
Hospital with a 1-week history of
fever and abdominal pain. Altered
mental status had developed shortly
after the onset of fever. He had
worked in the western part of
Singapore as a lifeguard at a commu-
nity swimming pool and had not trav-
eled, even to offshore islands, for the
past year.
On examination, he was febrile
with a temperature of 39.3°C and dis-
oriented to time and place. Nuchal
rigidity was present, and hyperreflexia
was demonstrated in both upper limbs,
although lower limb reflexes were
normal. The rest of the initial physical
examination was unremarkable.
Laboratory studies showed a
leukocyte count of 4.91 × 109/L,
hemoglobin concentration of 14.3
g/dL, and platelet count of 171 ×
109/L. Serum and liver biochemistry
results were normal. Magnetic reso-
nance imaging of the brain showed
mild leptomeningeal enhancement. An
electroencephalogram showed gener-
alized slow waves, consistent with
severe diffuse encephalopathy. A lum-
bar puncture was performed. The
opening pressure was elevated at 24
cm/H2O; cerebrospinal fluid (CSF)
leukocyte count was 192/mm3, con-
sisting mostly of lymphocytes; CSF
glucose was 2.4 mmol/L (44% of
serum glucose concentration); and
CSF total protein was elevated at 1.5
g/L. CSF and blood cultures for bacte-
ria, fungi, and mycobacteria were neg-
ative, as were CSF isolates for entero-
viruses and herpes simplex virus.
Results of paired acute- and con-
valescent-phase serologic testing for
dengue immunoglobulin M (IgM) and
IgG were negative, as were the micro-
scopic agglutination test for lep-
tospirosis and the Widal test for
typhoid. Subsequent polymerase
chain reaction (PCR) testing of serum
and CSF on day 10 of illness yielded
negative results for Nipah/Hendra
virus, West Nile virus, enterovirus,
herpesviruses, measles virus, and
alphaviruses. 
However, the patient’s serum but
not CSF tested positive for flavivirus
RNA when a universal flavivirus
reverse transcription (RT)–PCR assay
that targets the conserved sequence of
the NS5 region was used (3). JEV was
definitively identified as the etiologic
agent when the serum sample tested
positive with a second RT-PCR spe-
cific to the conserved sequences in the
NS3 region of the JEV genome, mod-
ified to a real-time platform (4).
Comparison of the 197-nt sequence of
this JEV-specific RT-PCR product
with the library of human, mouse, and
viral genome databases managed by
the National Center for Biotechno-
logy Information site using the
BLASTN program (available from
http://www.abcc.ncifcrf.gov/app/
htdocs/appdb/appinfo.php?appname)
showed 93% homology with reported
JEV sequences.
The patient had a prolonged and
complicated hospital stay. He became
comatose and went into type 2 respi-
ratory failure within 72 hours of hos-
pitalization; pinpoint pupils, brady-
cardia, and hypothermia developed.
These developments necessitated
mechanical ventilation at the medical
intensive care unit, where the patient
subsequently improved after 6 days of
supportive care and was extubated.
Flaccid paraparesis with urinary
retention developed at this point, and
magnetic resonance imaging of the
spine demonstrated signal enhance-
ment at the level of the conus
medullaris. Motor power gradually
improved with intensive rehabilitation
and was normal by the time of the
patient’s discharge 2 months after
admission. However, intermittent
self-catheterization was still required
for detrusor hyperreflexia.
This is the sixth case of JE report-
ed in Singapore from 1991 to July
2005. Three imported cases were
reported from 1991 to 2000. Two
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